Regulatory elements (REs) consist of enhancers and promoters that occupy a significant portion of the non-coding genome and control gene expression programs either in -cis or intrans. Putative REs have been identified largely based on their regulatory features (cooccupancy of ESC-specific transcription factors, enhancer histone marks and DNase hypersensitivity) in mouse embryonic stem cells (mESCs). However, less has been established regarding their regulatory functions in their native context. We deployed cis-and trans-regulatory elements scanning through saturating mutagenesis and sequencing (ctSCAN-SMS) to target elements within the ~12kb cis-region of the Oct4 gene locus, as well as genome-wide 2,613 high-confidence trans-REs (TREs), in mESCs. The ctSCAN-SMS identified 10 CREs and 12 TREs, as novel candidate REs of the Oct4 gene in mESCs. Furthermore, deletion of these REs confirmed that the majority of the CREs and TREs are functionally active, and involved in regulating Oct4 gene expression. Additionally, a subset of the functional CREs and TREs physically interact with the Oct4 promoter to varying degrees through intra-and inter-chromosomal interactions, respectively. Comparative genomics analysis reveals that functional CREs are more conserved in terms of their regulatory sequence conservation between mouse and primates (including humans) than TREs. Notably, a few active CREs are devoid of canonical regulatory features. Taken together, our work demonstrates the reliability and robustness of ctSCAN-SMS screening to identify critical REs, and probe their roles in the regulation of transcriptional output of a target gene (in this case Oct4).
Introduction
Large-scale genomic studies reveal that ~80% of the human genome may be involved in gene regulation, whereas only ~2% of the genome codes for proteins (ENCODE Project Consortium 2012) . The functional non-coding genome can be broadly divided into regulatory elements (REs) and regions that encode non-coding RNAs (ncRNAs) (ENCODE Project Consortium 2012; Cech and Steitz 2014) . Furthermore, REs can be sub-divided into cis-REs (CREs) and trans-REs (TREs), based on their position relative to their target gene(s). CREs are present proximally or distally relative to their target gene(s) on the same chromosome, whereas TREs are located distally relative to their target genes on different chromosomes (Miele and Dekker 2008; Elkon and Agami 2017) . Putative REs have been identified using various methods, including transcription factor binding, particular enhancer histone marks, DNA accessibility (open chromatin regions), enhancer-promoter interactions, and gene expression (Visel et al. 2009 ; ENCODE Project Consortium 2012; Mouse ENCODE Consortium et al. 2012; Roadmap Epigenomics Consortium et al. 2015; Ernst et al. 2011; Thurman et al. 2012; Buenrostro et al. 2013 ). REs enriched for sequence variants are associated with diverse human traits and diseases Andersson et al. 2014; Farh et al. 2015) . In addition, REs play crucial roles in evolutionary turnover and divergence (Vierstra et al. 2014; Stergachis et al. 2014; Villar et al. 2015; Siepel and Arbiza 2014) .
Initial efforts have systematically evaluated RE function using reporter assays on a massive scale (Melnikov et al. 2012; Patwardhan et al. 2012) ; such approaches fail to interrogate REs within their native genomic contexts. Advances in CRISPR-Cas9 mediated genome editing technology (Mali et al. 2013; Mojica et al. 2009 ) transform the ability to examine protein-coding genes Wang et al. 2014) , as well as REs in situ in chromatin. High-throughput CRISPR-Cas9 mediated functional genetic screens have been performed to characterize the CREs in mammalian cells (Canver et al. 2015; Korkmaz et al. 2016; Rajagopal et al. 2016; Diao et al. 2016; Sanjana et al. 2016) . Prior screens to identify functional CREs focused on targeting putative CREs of gene(s) of interest (gene-centric) or on targeting putative CREs bound by selected TFs (TF-centric). However, identification of functional TREs presents a challenge that has attracted less attention.
Here, we deployed genome-wide cis-and trans-regulatory elements scanning through saturating mutagenesis and sequencing (ctSCAN-SMS) in mouse embryonic stem cells (mESCs) to identify critical CREs and TREs of the Pou5f1/Oct4 gene (a master pluripotency regulator of mESCs). We uncovered new functionally active CREs and TREs, and how they regulate Pou5f1/Oct4 gene expression in mESCs.
Results

Design of a saturating CRISPR-Cas9 pooled library for ctSCAN-SMS
In mESCs, several putative REs, including 8,563 enhancers (ENs) and 231 super-enhancers (SEs) have been identified based on co-occupancy of ESC-specific TFs (OCT4, NANOG, SOX2, KLF4, ESSRB), mediators (MED1), enhancer histone marks (H3K4me1, H3K27ac) and DNase I hypersensitivity (Whyte et al. 2013) . SEs contain multiple ENs; SEs are also more densely co-occupied with TFs, enhancer histone marks, and chromatin regulators as compared to ENs, with a higher magnitude of transcriptional output (Whyte et al. 2013) . We undertook a high-throughput CRISPR-Cas9 mediated genome editing approach to target all putative REs. First, we generated a genome-wide map of open chromatin regions using ATAC-seq in mESCs, as ATAC-seq identifies most EN REs (Buenrostro et al. 2013) . ATACseq peaks were then overlapped with all putative ENs (8, 563) and SEs (231) to designate high-confidence REs (2,613) ( Fig. 1A ; Supplemental S1A; Supplemental Table 1 ). As these REs are distributed genome-wide and on different chromosomes relative to Oct4 gene locus (in trans-), we termed these REs as TREs. All possible single guide RNAs (sgRNAs) (20 nt) were designed (within the TREs for tilling) upstream of the S. pyogenes Cas9 NGGprotospacer adjacent motif (PAM) sequences to target the high-confidence TREs ( Table 1 , 2). This analysis created 70,480 sgRNAs with a median gap of 5 bp between adjacent genomic cleavages (Fig. 1C, 1D) . Similarly, 1,827 sgRNAs were created at the surrounding ~12kb (-10kb to +2kb of TSS of the Oct4) region of the mouse Oct4 gene locus to systematically dissect the cis-REs (CREs) of Oct4 (Fig. 1B,   1C ). In addition, the library included 2,000 non-targeting (NT) sgRNAs as negative controls; 119 sgRNAs targeting GFP (of the Oct4-GFP reporter that used for the screen), and 150 sgRNAs targeting coding sequence of mESC-TFs as positive controls (Fig. 1C ). In total, the REs CRISPR-Cas9 pooled library contained 74,576 sgRNAs (Fig. 1C) . These sgRNAs were synthesized, pooled together, cloned into a lentiviral vector, and deep sequenced. The deep sequencing result represents >95% sgRNAs that target TREs, >99% sgRNAs that target CREs and control sgRNAs in the pooled library ( Fig.1C ; Supplemental Fig.S1B-S1F; Supplemental Table 2 ).
Candidate CREs and TREs of the Oct4 gene identified by ctSCAN-SMS
The pooled library was transduced into an Oct4-GFP reporter mESC line, which constitutively expresses Cas9 (Yeom et al. 1996; Seruggia et al. 2019 ) (Supplemental Fig. S2B ). The Oct4-GFP reporter was used as a "readout" for the screen to measure the reduction in GFP levels upon perturbation of any targeted RE regions by their corresponding sgRNAs. Lentiviral transduction of the pooled library was performed at low multiplicity (MOI) to ensure that each cell contained predominantly one sgRNA (Supplemental Fig. S2A ). After drug selection, "GFPlow" cells were sorted using fluorescence-activated cell sorting (FACS) (Supplemental Fig.   S2A , S2C). As a control, cells were collected before FACS (the "pre-sort" sample). Genomic DNA was isolated from both GFP-low and pre-sort cell populations, and next-generation sequencing (NGS) was employed to enumerate the sgRNAs in each cell population (Supplemental Fig. S2A ). The screen was performed in triplicate.
We calculated an "enrichment score" of each sgRNA by comparing its frequency in GFP-low over pre-sort cells. The enrichment scores were built based on the two best replicates (Supplemental Table 2 ). As expected, highest and lowest enrichment scores were obtained from GFP-targeting sgRNAs (mean log2FC 4.87 ± 1.16, P<0.0001) and NT-sgRNAs (mean log2FC 0.44 ± 0.74, P<0.0001) respectively, indicating that the screen was technically successful ( Fig. 2A, 3A ). We ranked all sgRNAs based on their enrichment scores (Supplemental Table 2 ), and analyzed their off-target scores (ranged between 0-100) (Hsu et al. 2013) (Supplemental Fig. S3A, S4A; Supplemental Table 2) . A higher off-target score signifies fewer off-targets for a particular sgRNA. We found that the majority of the evaluated sgRNAs (87.6% sgRNAs for CREs, and 84.5% sgRNAs for TREs) have off-target scores >10 (Supplemental Table 2 ).
To identify candidate CREs of the Oct4, we considered all sgRNAs with off-target scores >10 and mapped them within the ~12kb surrounding region (-10kb to +2kb of TSS) of the Oct4 gene locus. This yielded 16 candidate CREs (1-16), based on the mean enrichment score (mean log2FC) of sgRNAs per CRE. Each of the candidate CREs had a mean log2FC>0.5, P<0.0001, which was higher than the mean enrichment score of NT-sgRNAs (mean log2FC 0.44 ± 0.74, P<0.0001) ( Fig. 2A, 2B ). Among 16 CREs, CREs-10 and 12 have been recognized previously as distal and proximal enhancers, respectively (Yeom et al. 1996) ;
CREs-13 to 16 were present within the promoter region of Oct4 (+/-2kb of TSS) (Yeom et al. 1996) . The remaining 10 CREs were newly identified candidate CREs of the Oct4 gene ( Fig.   2A , 2B).
To classify the candidate TREs, we applied a Hidden Markov Model (HMM) to the sgRNAs enrichment scores (Canver et al. 2017) , which initially identified 263 candidate TREs. Furthermore, we applied stringent criteria to select candidate TREs for validation, as follows: i) TREs must have sgRNAs with off-target scores>10 ( Fig. S4C ). Based on these criteria, we selected
Dissection of functionally active CREs and TREs of the Oct4 gene
We selected a total of 33 REs, including 20 CREs -16 CREs and 4 control CREs (CREs without any sgRNAs), and 13 TREs -12 TREs and one control TRE (without any sgRNAs) of the Oct4 gene locus for validation. Paired sgRNAs (5' and 3' sgRNAs with mCherry) were used to target the flanking ends of each selected candidate RE to create a deletion. The paired sgRNAs tagged with mCherry were transfected to the wild-type mESCs; mCherry-positive cells were sorted and endogenous Oct4 mRNA expression levels were measured ( Fig. 2F,   3E ). We observed significant reduction in Oct4 expression to different extents upon deletion of CREs-1, 3, 5, 7, 10, 12, and 13-16 ( Fig. 2F ). Deletions of newly identified CREs-1, 3, 5 and 7 showed greater reduction in Oct4 expression, compared to deletions of known distal and proximal enhancers (CREs-10 and 12) of Oct4 (Fig. 2F ). However, co-occupancy of ESC-TFs (OCT4, NANOG, SOX2-ONS), enhancer histone marks (H3K27ac, H3K4me1) and dynamic open chromatin regions (ATAC-seq peaks at 0, 8 hr compared to 24, 96hr) were more prominent at CREs-7, 10, 12 compared to CREs-1, 3, 5 ( Fig Deletion of several TREs 2, 3, 4, 7, 9, 11, 12 ) exhibited a substantial reduction in Oct4 expression to various extents ( Fig. 3E ). Nonetheless, all TREs revealed co-occupancy with ONS, H3K27ac and H3K4me1 marks, as well as with dynamic open chromatin regions ( Fig. 3C, 3D ; Supplemental Fig. S4B, S4C ). This is an agreement with all the candidate TREs (TREs 1-12) that were short-listed for validation based on their regulatory features. Conversely, control TRE did not contain any regulatory features ( Fig. 3C, 3D) ; and deletion of the control TRE did not affect Oct4 expression ( Fig. 3E) . Interestingly, we observed that the majority of the neighbouring genes of validated TREs were lowly expressed in mESCs (Supplemental Fig. S4D ). This suggests that -i) the active TREs are not the actual REs of their neighbouring genes; and/or ii) these genes are unrelated to the mESC state.
Taken together, these data validate the function of a subset of the newly identified candidate CREs and TREs of the Oct4 gene. Also, our findings support the reliability and robustness of the ctSCAN-SMS screen to identify critical REs of the Oct4 in a high-throughput manner.
Cis-and trans-regulation of the Oct4 gene expression
REs (particularly enhancers) physically interact with the promoter of a gene, and control transcription (Murakawa et al. 2016) . Several chromosome conformation capture (3C) based methods -4C, Hi-C, capture Hi-C, ChiA-PET and HiChIP have been utilized to identify physical contacts between promoters and REs (enhancers) in order to evaluate the significance of the REs (Elkon and Agami 2017; Mumbach et al. 2016) . To interrogate the potential mechanisms by which candidate CREs and TREs regulate Oct4 gene expression, we examined interactions between REs (CREs and TREs) and the Oct4 promoter using published 4C-seq data. These data were generated to study intra-chromosomal and interchromosomal interactions between REs and the Oct4 promoter at a genome-wide scale (van de Werken et al. 2012) . We used Oct4-234 (a region at 1.5kb upstream of TSS of Oct4) as a viewpoint, as previously (Supplemental Fig. S5A ); calculated contact frequencies between the viewpoint and CREs (using 1kb resolution window, surrounding 30kb region of the Oct4 gene locus) ( Fig. 4A, 4C ), as well as contact frequencies between the viewpoint and TREs (using 50kb resolution window, surrounding each of the TRE) ( Fig. 4B ). This analysis revealed ranges of contact frequencies between functionally validated active CREs/TREs and the Oct4 promoter. For example, newly identified CREs-3, 5, 7, as well as CREs-10 and 12 (known distal and proximal enhancers of Oct4), and CREs-13 to16 (residing at the promoter region of Oct4) demonstrated significant intra-chromosomal interactions with the Oct4 promoter ( Fig.   4A, 4C) . In contrast, we failed to detect significant interactions of CRE-1 with the Oct4 promoter, similar to the four control CREs (Fig. 4A, 4C ). Likewise, validated active 2, 3, 4, 7, 9, 11, 12 also exhibited a degree of inter-chromosomal interactions with the Oct4 promoter ( Fig. 4B ). Taken together, our data suggest that active CREs and TREs physically interact with the Oct4 promoter to different extent as they influence Oct4 expression.
Conserved functionally active CREs and TREs of the Oct4 gene
Recent studies demonstrate that the majority of species-specific REs/ ENs evolved de novo from ancestral DNA regulatory sequences (Villar et al. 2015; Long et al. 2016) . Also, evidence implies that loss and gain of REs (called turnover) takes place during evolution (Siepel and Arbiza 2014) . To understand the importance of validated active CREs and TREs of mouse Oct4 in evolutionary turnover, we analyzed their regulatory sequence conservation along with evolved species, such as primates including human. CREs-3, 5; CREs-10 and 12 (known distal and proximal ENs); CREs-13 to 16 (present within the promoter) demonstrated significant conservation between mouse and primates ( Fig. 5A ); whereas active CREs-1, 7 did not show appreciable sequence conservation with primates ( Fig. 5A ). In comparison to CREs, only a few active TREs (TREs-3 and 4) showed significant sequence conservation between mouse and primates, including human ( Fig. 5B, 5C ).
Next, we analyzed regulatory sequence conservation of previously identified highconfidence CREs (-449, -571, -694) of human OCT4. These CREs are located distally between ~450 to 700kb upstream of the human OCT4 TSS, and physically interact with the OCT4 gene (Diao et al. 2017) . Surprisingly, we found that these human CREs are evolutionary conserved at the upstream regions of the mouse Oct4 locus as well (Supplemental Fig. S6A ).
Taken together, our comprehensive comparative genomic analysis shows that several functional CREs and TREs (but not all REs) of Oct4 are well-conserved between mouse and primates including human. These data support the occurrence of REs turnover/divergence (gain and loss of REs) and its activity at the Oct4 locus during evolution, which may be critical for positive selection as proposed earlier (Siepel and Arbiza 2014; Long et al. 2016) .
Discussion
A handful of small to large scale CRISPR-Cas9 mediated functional screens (using hundreds to thousands of sgRNAs) have been performed to target specific non-coding CREs of gene(s) of interest (Canver et al. 2015; Korkmaz et al. 2016; Rajagopal et al. 2016; Sanjana et al. 2016; Fulco et al. 2016 ). All these screens were successful in identifying functional CREs of the target gene(s). In the context of identification of CREs of the OCT4 gene, a previous CRISPR-Cas9 mediated screen was performed to target 174 candidate CREs of OCT4 within its 1MB topological associated domain (TAD) in human ESCs; it revealed 4 temporary CREs and 2 known proximal CREs. The temporary CREs show "transient" enhancer regulatory activity in OCT4 gene expression (Diao et al. 2016 ). However, the functional relevance of these temporary CREs is uncertain in human OCT4 gene regulation. Furthermore, another CRISPR-Cas9 mediated screen was performed by the same group using a different strategy, called CREST-seq. This method was applied to design 11,570 paired sgRNAs to introduce deletions to target 2Mb surrounding the OCT4 locus in human ESCs (hESCs), which created 2kb deletions on average with an overlap of 1.9kb between two adjacent deletions. This screen identified total 45 CREs, of which 17 CREs (with regulatory features) reside at the promoters of "unrelated" genes (intra-chromosomally) that act as typical enhancers of the OCT4 gene (Diao et al. 2017 ). Our study employed ctSCAN-SMS -an unbiased, high-resolution, highthroughput screening approach using 1,827 sgRNAs to target CREs and 70,480 sgRNAs to target TREs of the mouse Oct4 gene (Fig. 1) . Previous CRISPR-Cas9 screens identified mostly CREs of the target gene(s). In contrast, our screen was designed to identify both CREs and TREs. Indeed, we discovered 16 CREs (including 10 novel CREs) and 12 novel TREs of the Oct4 gene, as potential candidate REs ( Fig. 2A, 3A) . Deletion studies confirmed that the majority of these CREs and TREs are functionally "active" for controlling Oct4 expression; however, CREs are more active than TREs (Fig. 2F, 3E ). In addition, we showed that a subset of active CREs and TREs physically interacts with the Oct4 promoter to different extents through intra-and inter-chromosomal interactions, respectively (Fig. 4A, 4B) ; as described previously in other gene regulatory contexts (Miele and Dekker 2008) . Nonetheless, "enhancer activity" of REs is not directly correlated to their physical contact intensity with the Oct4 promoter ( Fig. 2F, 3E , 4A-4C). Interestingly, we found a few active CREs (CREs-1, 3) that lack typical regulatory features ( Fig. 2D-2F ). These observations support earlier studies that identified unmarked REs (UREs) with no typical regulatory features, yet play critical roles in transcriptional output (Rajagopal et al. 2016; Diao et al. 2017) . Moreover, comparative genomics analysis revealed that several active CREs and a few TREs of Oct4 are evolutionarily conserved (regarding their regulatory sequences) between mouse and primates, including human ( Fig. 5) . Though, we observed divergence of Oct4 REs among mouse and primates (including human), which may account for the vital roles of RE turnover during evolution for positive selection (Miele and Dekker 2008; Long et al. 2016 ).
Several studies demonstrate that "multiple" REs act either in a co-operative or competitive fashion to control transcriptional output (Long et al. 2016 ). Our study identified multiple active REs of Oct4, and revealed a spectrum of regulatory activities of individual CREs and TREs in Oct4 gene expression ( Fig. 2F, 3E ). Further systematic studies will be required to elucidate how multiple REs function combinatorially to control the transcriptional output of the Oct4 locus. In conclusion, we have demonstrated the utility of ctSCAN-SMS as an approach to identify functional CREs and TREs of a gene locus, and dissect their regulatory contributions to the transcriptional output of a target within its normal chromosomal setting.
Methods
Mouse embryonic stem cells (mESCs)
Mouse ESCs (mESCs) were cultured in mouse ESC media that contains DMEM (Dulbecco's modified Eagle's medium) (Thermo Fisher Scientific) supplemented with 15% fetal calf serum (FCS) (Merck Millipore), 0.1mM b-mercaptoethanol (Sigma-Aldrich), 2mM L-glutamine (Thermo Fisher Scientific), 0.1mM nonessential amino acid (Thermo Fisher Scientific), 1% of nucleoside mix (Merck Millipore), 1000 U/ml recombinant leukemia inhibitory factor (LIF/ESGRO) (Merck Millipore), and 50U/ml Penicillin/Streptomycin (Thermo Fisher Scientific), as described previously (Seruggia et al. 2019; Das et al. 2014) . mESCs were cultured at 37 º C, 5% CO 2 .
Differentiation of mouse embryonic stem cells (mESCs)
ZHBTc4 mESCs (Niwa et al. 2000) were cultured in mESC media with all the supplements, including LIF. This was able to maintain the undifferentiated mESC state. Upon addition of doxycycline (2µg/ml) with mESC media+LIF in ZHBTc4 mESCs, they lead to decrease in Oct4 expression level and undifferentiated mESCs facilitate towards the differentiation (Whyte et al. 2012) . For ATAC-seq experiments, ZHBTc4 mESCs were treated with mESC media containing LIF and doxycycline, and the cells were collected after 0, 8, 24, 96 hr. These cells were washed with 1X PBS, counted, and proceeded to ATAC-seq library preparation.
Mouse REs CRISPR-Cas9 pooled library design for the ctSCAN-SMS
For this study, we selected a list of putative 8,563 enhancer (EN) and 231 super-enhancer (SE) REs from the mESCs, as described previously (Whyte et al. 2013) . First, we generated ATAC-seq (Buenrostro et al. 2013 ) data from wild-type mESCs, and mapped within all the putative EN and SE REs to identify open chromatin regions, as well as high-confidence REs.
Next, ±100 bp (200 bp) around the centre of the ATAC-seq peaks were obtained from the high-confidence REs. In total, we identified 2,613 REs for targeting. All possible single guide RNAs (sgRNAs) (20nt) were designed upstream of the S. pyogenes Cas9 NGG-protospacer adjacent motif (PAM) sequences at these defined REs (2,613), which created 70,480 sgRNAs with a median gap 5 bp between adjacent genomic cleavages. Since these EN and SE REs distributed in trans-of the Oct4 gene locus, we called these REs as trans-REs (TREs).
Likewise, 1,827 sgRNAs were designed prior to all possible NGG-PAM sequences at the adjacent ~12kb (-10kb to +2kb of TSS of Oct4) region of the mouse Oct4 gene locus to systematically dissect the REs of Oct4. As these REs reside adjacent to the Oct4 gene locus, they are called cis-REs (CREs). We also included 2,000 non-targeting (NT) sgRNAs as negative controls; 119 sgRNAs targeting GFP of the Oct4-GFP reporter and 150 sgRNAs targeting coding sequence of mESC-TFs as positive controls. Altogether, the REs CRISPR-Cas9 pooled library contained total 74,576 sgRNAs.
REs CRISPR-Cas9 pooled library construction for the ctSCAN-SMS
All the sgRNA oligonucleotides of the library were synthesized as previously described (Seruggia et al. 2019 ) using a B3 synthesizer (CustomArray, Inc.), pooled together, PCR amplified and cloned into Esp3I-digested plentiGuide-Puro (Addgene plasmid ID: 52963) lentiviral vector, using a Gibson assembly master mix (New England Biolabs).Gibson assembly products were transformed into electrocompetent cells (E. cloni, Lucigen) and plated on 245mm x 245mm square LB-agar plates to obtain the sufficient number of bacterial colonies at a ~50× library coverage. Bacterial colonies were collected from the plates, genomic DNA was isolated and plasmid libraries were prepared for high-throughput sequencing to confirm the representation of individual sgRNA in the REs CRISPR-Cas9 pooled library.
Lentiviral library production
HEK293T cells were seeded onto 15cm dishes ~24hrs prior to transfection. Cells were transfected at 80% confluence in 16ml of media with 8.75μg of VSVG, 16.25μg of psPAX2, and 25μg of the REs CRISPR-Cas9 pooled lentiviral plasmids, using 150μg of linear polyethylenimine (PEI) (Sigma-Aldrich). Media was changed with fresh media, 16-24hrs after transfection. Lentiviral supernatant was collected at 48 and 72hrs post-transfection and subsequently concentrated by ultracentrifugation (24,000 rpm, 4ºC, 2hrs) (Beckman Coulter SW32).
CRISPR-Cas9 mediated ctSCAN-SMS in mESCs
Oct4-GFP reporter mESCs with stably expressed Cas9 were transduced with REs CRISPR-Cas9 pooled lentiviral library at low multiplicity of infection (MOI) to avoid more than one lentiviral integration per cell. Test transductions were performed to estimate the viral titration and transduction rate. Briefly, 300,000 Oct4-GFP+Cas9 mESCs were plated per well of a 12well plate. After 24hrs, different amounts of (1, 2, 4, 6, 8µl) of the lentiviral library was added to the cells. 10μg/ml blasticidin (InvivoGen) and 1μg/ml puromycin (Sigma-Aldrich) were added 24hrs after the transduction to select for lentiviral library integrants (puromycin resistant) in cells with Cas9 (blasticidin resistant). Cells were selected for the next 3-4 days.
The same number of cells were seeded as a control; but not infected with lentiviral library and not treated with blasticidin and puromycin. The number of blasticidin and puromycin resistant cells and control cells were counted to calculate the viral titre and transduction rate (to achieve 30%).
For the actual screen, we seeded ~112 million (~75K sgRNAs in the pooled library, with 500X coverage, for 30% transduction rate) Oct4-GFP+Cas9 mESCs in the same format (i.e. 300K cells/ well of the 12-well plate) for each independent screening replicate. Lentiviral library was added to each well of 12-well plate to achieve 30% transduction rate with low MOI (MOI 0.1) to make sure each infected cell obtained one viral particle. 24hrs post-transduction, fresh mESC media was added to the cells with 10μg/ml blasticidin (InvivoGen) and 1μg/ml puromycin (Sigma-Aldrich) and selected for 4 days. These selected cells were used to sort the GFP-low cells. The pre-sort cells were collected before sorting and used as a control.
Genomic DNA was isolated from both the GFP-low and pre-sort cell populations, libraries were prepared for deep sequencing to enumerate the presence of sgRNAs in these cell populations as previously described (Seruggia et al. 2019 ). The screening was performed in biological triplicates.
Deletion of CREs and TREs of Oct4 in mESCs
Paired sgRNAs (5' and 3' sgRNAs) were designed to target both the ends of each selected candidate RE to create a deletion. Both the sgRNAs were cloned into lentiguide-puro plasmid that carries Cas9 and mCherry, using Golden Gate Cloning approach as previously described (Seruggia et al. 2019) . 100,000 wild-type (J1) mESCs were transfected with 500ng of each 5' and 3' sgRNA-Cas9-mCherry-puro plasmids using Lipofectamine 2000 (Thermo Fisher Scientific). After 24hrs of transfection, 10μg/ml blasticidin (InvivoGen) and 1μg/ml puromycin (Sigma-Aldrich) drugs were added to select the cells for the next 3-4 days. Next, drug-resistant cells were used to sort the mCherry-positive cells; at least 50,000 mCherry-positive cells were collected to isolate the total RNA and measure the Oct4 mRNA expression levels by quantitative RT-PCR.
Flow cytometry
Cells were dissociated using trypsin, washed with 1XPBS, followed by sorting. i) During the CRISPR-Cas9 screening, Oct4-GFP reporter mESCs were sorted based on GFP-low intensity after the transduction with REs CRISPR-Cas9 pooled library; ii) to quantify the Oct4 mRNA expressions upon deletions of CREs and TREs, their targeting sgRNAs-mCherry-positive cells were sorted.
RNA isolation and RT-qPCR
DNA-free total RNA was isolated from mESCs using RNeasy Mini Kit (Qiagen), and cDNA was prepared using iScript cDNA Synthesis Kit (Bio-Rad). RT-qPCR was performed using iQ SYBR Green Supermix (Bio-Rad) on Bio-Rad iCycler RT-PCR detection system.
ctSCAN-SMS screen data analysis
sgRNA sequences present in the GFP-low and pre-sort pools were enumerated. Enrichment was determined by the log2 transformation of the median number of occurrences of a particular sgRNA in the GFP-low pool divided by the median number of occurrences of the same sgRNA in the pre-sort pool across the best two biological screen replicates.
ATAC-seq experiment and data analysis
ATAC-seq was performed according to the previously described protocol (Buenrostro et al. 2013) , with some modifications. We used J1 wild-type mESCs; and ZHBTc4 mESCs from 0, 8, 24, 96hr after the doxycycline treatment. Briefly, each library was started with 50,000 cells, which were washed with 1X PBS and permeabilized with 50µl of lysis buffer (10mM Tris, pH 7.4; 10mM NaCl; 3mM MgCl2; 0.1% IGEPAL) at 4 0 C by resuspension. Cells were centrifuged at 500g for 10 min at 4 0 C to pellet the nuclei. The resulting nuclei were resuspended in 50µl of transposition reaction buffer (25µl of 2x TD buffer from the Nextera kit, Illumina; 2.5µl of Tn5 transposase enzyme from the Nextera kit, Illumina; 22.5µl of nuclease free water), and incubated at 37 0 C for 90 min for chromatin tagmentation. Next, DNA was purified using Qiagen MinElute PCR purification kit, and eluted in 10µl of nuclease-free water. PCR amplification was performed using Nextera primers (Illumina) to make the libraries for deep sequencing.
The obtained deep sequencing data in .FASTQ format was inspected first by FASTQC.
Next, reads were trimmed for adapters using Trimmomatic (Bolger et al. 2014 ). The resulting fastq files were aligned with Bowtie2 (Langmead and Salzberg 2012) with the following options --local -X 2000. Peaks were called with MACS2 (Zhang et al. 2008 ) with the following options callpeak --gsize mm --nomodel --shift -100 --extsize 200 --call-summit.
4C-seq data analysis
The normalised interaction frequencies between CREs and Oct4 promoter measured based on 4c-seq pipeline (van de Werken et al. 2012), with some modification. Normalised interaction frequencies between CREs and Oct4 promoter (Oct-234 used as a view point) was quantified at a higher resolution (1kb resolution window compared to previous analysis used 7kb resolution window). We used the following command: perl 4cseqpipe.pl -dopipe -ids 1 -fastq_fn Oct4/fastq/Oct4_234.fastq -convert_qual 1 -calc_from 35620000 -calc_to 35660000 -stat_type median -trend_resolution 1000 -figure_fn Oct4_234_1K.pdf -feat_tab rawdata/Oct4_234_features.txt
The contact frequencies between TREs and Oct4 promoter was calculated based on the number of contacts between the Oct4 promoter (Oct4-234 used as a view point) and a 50kb region centred at each TRE, using bedtools intersect command.
Data access
All the high-throughput sequencing data from this study have been submitted to the NCBI RNAseq Enriched sgRNAs (GFP-low/presort)
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CGT TGGGGT TCTGGGT CACCTCT T T TCTCCCGGC T T T T CCCTCGCTCTCCGGT T CC TGA A T T AGCTGT T TGT T T A TGGCTCCAGACGTGTGTGCCAGCGAGCCGAGGCAGCGTGCA AGGGAGA A A A T TGA TCT T T CCTCAGACTCAAAGC TGGAGCCGA AGA AGTGCGGGGGA
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